Log In
BCIQ
Print this Print this
 

PEG-irinotecan

  Manage Alerts
Collapse Summary General Information
Company JenKem Technology Co. Ltd.
DescriptionLong-acting polymer-drug conjugate that inhibits topoisomerase I (TOP1)
Molecular Target Topoisomerase I (TOP1)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner3SBio Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/16/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today